These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28694965)

  • 21. Urinary peptidomic biomarkers of renal function in heart transplant recipients.
    Huang QF; Zhang ZY; Van Keer J; Trenson S; Nkuipou-Kenfack E; Yang WY; Thijs L; Vanhaecke J; Van Aelst LNL; Van Cleemput J; Janssens S; Verhamme P; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2019 Aug; 34(8):1336-1343. PubMed ID: 29982668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker.
    Pontillo C; Zhang ZY; Schanstra JP; Jacobs L; Zürbig P; Thijs L; Ramírez-Torres A; Heerspink HJL; Lindhardt M; Klein R; Orchard T; Porta M; Bilous RW; Charturvedi N; Rossing P; Vlahou A; Schepers E; Glorieux G; Mullen W; Delles C; Verhamme P; Vanholder R; Staessen JA; Mischak H; Jankowski J
    Kidney Int Rep; 2017 Nov; 2(6):1066-1075. PubMed ID: 29130072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the reliability of MS1-based approach to profile naturally occurring peptides with clinical relevance in urine samples.
    Jiang J; Zhan L; Dai L; Yao X; Qin Y; Zhu Z; Zhang M; Tong W; Wang G
    Rapid Commun Mass Spectrom; 2022 Jul; ():e9369. PubMed ID: 35906701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease.
    Cañadas-Garre M; Anderson K; McGoldrick J; Maxwell AP; McKnight AJ
    J Proteomics; 2019 Feb; 193():93-122. PubMed ID: 30292816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.
    Siwy J; Zürbig P; Argiles A; Beige J; Haubitz M; Jankowski J; Julian BA; Linde PG; Marx D; Mischak H; Mullen W; Novak J; Ortiz A; Persson F; Pontillo C; Rossing P; Rupprecht H; Schanstra JP; Vlahou A; Vanholder R
    Nephrol Dial Transplant; 2017 Dec; 32(12):2079-2089. PubMed ID: 27984204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding glomerular diseases through proteomics.
    Mavrogeorgis E; Mischak H; Beige J; Latosinska A; Siwy J
    Expert Rev Proteomics; 2021 Feb; 18(2):137-157. PubMed ID: 33779448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome.
    Cherney D; Perkins BA; Lytvyn Y; Heerspink H; Rodríguez-Ortiz ME; Mischak H
    PLoS One; 2017; 12(10):e0186910. PubMed ID: 29084249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease.
    Catanese L; Siwy J; Mavrogeorgis E; Amann K; Mischak H; Beige J; Rupprecht H
    Proteomes; 2021 Jul; 9(3):. PubMed ID: 34287333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The urinary proteome as correlate and predictor of renal function in a population study.
    Gu YM; Thijs L; Liu YP; Zhang Z; Jacobs L; Koeck T; Zürbig P; Lichtinghagen R; Brand K; Kuznetsova T; Olivi L; Verhamme P; Delles C; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2014 Dec; 29(12):2260-8. PubMed ID: 24981581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Use of 'Omics for Diagnosing and Predicting Progression of Chronic Kidney Disease: A Scoping Review.
    Govender MA; Brandenburg JT; Fabian J; Ramsay M
    Front Genet; 2021; 12():682929. PubMed ID: 34819944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria.
    Oellgaard J; Gæde P; Persson F; Rossing P; Parving HH; Pedersen O
    J Diabetes Complications; 2018 Dec; 32(12):1133-1140. PubMed ID: 30282584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures!
    Mischak H
    Nephrol Dial Transplant; 2015 Apr; 30(4):532-7. PubMed ID: 25801638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase.
    Sanchez-Niño MD; Sanz AB; Ramos AM; Fernandez-Fernandez B; Ortiz A
    Clin Kidney J; 2017 Apr; 10(2):188-191. PubMed ID: 28396735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates.
    Farmakis D; Koeck T; Mullen W; Parissis J; Gogas BD; Nikolaou M; Lekakis J; Mischak H; Filippatos G
    Eur J Heart Fail; 2016 Jul; 18(7):822-9. PubMed ID: 27220540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study.
    Kanzelmeyer NK; Zürbig P; Mischak H; Metzger J; Fichtner A; Ruszai KH; Seemann T; Hansen M; Wygoda S; Krupka K; Tönshoff B; Melk A; Pape L
    Transpl Int; 2019 Jan; 32(1):28-37. PubMed ID: 30357927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery disease.
    Stanley E; Delatola EI; Nkuipou-Kenfack E; Spooner W; Kolch W; Schanstra JP; Mischak H; Koeck T
    BMC Bioinformatics; 2016 Dec; 17(1):496. PubMed ID: 27923348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients.
    Markoska K; Pejchinovski M; Pontillo C; Zürbig P; Jacobs L; Smith A; Masin-Spasovska J; Stojceva-Taneva O; Polenakovic M; Magni F; Mischak H; Spasovski G
    Nephrol Dial Transplant; 2018 May; 33(5):751-759. PubMed ID: 28992073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary proteomic signatures associated with β-blockade and heart rate in heart transplant recipients.
    Huang QF; Van Keer J; Zhang ZY; Trenson S; Nkuipou-Kenfack E; Van Aelst LNL; Yang WY; Thijs L; Wei FF; Ciarka A; Vanhaecke J; Janssens S; Van Cleemput J; Mischak H; Staessen JA
    PLoS One; 2018; 13(9):e0204439. PubMed ID: 30248148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary Biomarkers of Renal Fibrosis.
    Zhou LT; Lv LL; Liu BC
    Adv Exp Med Biol; 2019; 1165():607-623. PubMed ID: 31399987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.